A shadow economy for unapproved weight-loss medications is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.
Investigational Drug Gaining Popularity Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Followers are encouraged to contact these profiles directly for supplier links, while also obtaining discount codes.
Thriving Trade on Social Networks
Separately, a flourishing market exists on Telegram, where communities with thousands of participants share comparison photos, administration instructions and claims of rapid UK delivery. Vendors promote the substance there before redirecting customers to WhatsApp for purchases.
Understanding Retatrutide
This medication is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Medical Experts Voice Worries
However, physicians and pharmacists have warned that the sale of what remains an unlicensed medication in the United Kingdom is worrisome and could result in individuals injecting products of unknown origin.
Several professionals stated the popularity for the experimental drug could be linked to the increasing cost of licensed slimming products such as Mounjaro.
Regulatory Status and Implementation
Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved drug that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.
Some content creators attempt to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to fines, prosecution or imprisonment.
Platform Response and Material Removal
According to the social media company, the platform has removed violative content and prohibited related keywords and search suggestions. The organization said it was committed to keeping the service secure and allocating resources in enhancing compliance measures.
Online Trading Operations
Investigations also discovered communities with up to nine thousand participants marketing retatrutide using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly brings up channels with thousands of members, filled with photos of slimming results, positive reviews and detailed guides for preparing or administering at residence.
Within minutes of entering one community, a vendor posted WhatsApp details, where most purchases take place. The vendor provided an instruction manual and promised delivery within two days. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None asked about weight, medical conditions or past usage.
Product Information and Pricing
Inside these groups, messages display dark colored parcels with Royal Mail stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at residence with sterile water, or pre-filled pens typically sold at £160 for 20mg. When asked how long a pen should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Platform Oversight and Safety Actions
A representative for the messaging service said it regularly monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are administering materials they cannot confirm. Even if the science behind this drug is sound, these digital versions may not contain what they claim,” stated Jason Murphy, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current price rises for approved slimming medications such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit injections are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained.
Her team has already encountered individuals injured by self-injection from unverified sources. “We recognize the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be contaminated or improperly measured.”
Producer Statement
A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they said, adding that any product “falsely representing itself as a company investigational product not yet authorized … may expose users to possibly serious medical dangers”.
